Literature DB >> 26828290

Evaluation of the Anterior Segment Parameters of the Patients with Scleroderma.

Muhammed Şahin1, Harun Yüksel1, Alparslan Şahin1, Abdullah Kürşat Cingü1, Fatih Mehmet Türkcü1, Savaş Kaya2, Levent Yazmalar3, İbrahim Batmaz3.   

Abstract

PURPOSE: To evaluate corneal parameters of scleroderma (SC) patients by Pentacam-HR.
METHODS: Twenty-two eyes of 22 SC patients and 33 eyes of 33 control subjects were enrolled. All participants underwent Pentacam (Pentacam-HR, Oculus, Germany) evaluation. Both SC and control groups were divided into two subgroups as dry eye (DE) (Schirmer test with topical anesthesia (STA) ˂5 mm) and without DE (STA ˃5 mm).
RESULTS: Pachymetric measurements and mean corneal volume (CV) were significantly lower in the SC group than in the control group (p<0.001). Pachymetric measurements and CV of SC patients with DE were significantly lower than all the other subgroups. Control subgroups with or without DE were similar in pachymetric measurements and CV.
CONCLUSIONS: The results suggest that SC patients have thinner corneas compared with control subjects. Additionally, coexistence of DE seems to have an additional impact in the thinning of cornea in SC patients.

Entities:  

Keywords:  Corneal thickness; Scheimpflug imaging; corneal volume; dry eye; inflammatory diseases; scleroderma

Mesh:

Year:  2016        PMID: 26828290     DOI: 10.3109/09273948.2015.1115079

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy.

Authors:  Huseyin Mayali; Muhammed Altinisik; Secil Sencan; Timur Pirildar; Emin Kurt
Journal:  Int Ophthalmol       Date:  2019-09-28       Impact factor: 2.031

2.  Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.

Authors:  Aniko Rentka; Annamaria Nagy; Jolan Harsfalvi; Gabriella Szucs; Zoltan Szekanecz; Rudolf Gesztelyi; Peter Szodoray; Adam Kemeny-Beke
Journal:  Rheumatol Int       Date:  2017-09-07       Impact factor: 2.631

Review 3.  Ocular manifestations of rheumatic diseases.

Authors:  Adam Kemeny-Beke; Peter Szodoray
Journal:  Int Ophthalmol       Date:  2019-10-03       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.